Hussain Mustafa
Bowel Movement & Poo Tracker
Snapshot
Publisher DNA
What defines Hussain Mustafa?
AI intelligence is not yet available for Hussain Mustafa. The portfolio data below is up to date.
Portfolio
What does Hussain Mustafa ship?
Apps
23 apps analysed
Analysis in progress
Analysis in progress
Vitamin compliance reminders create daily retention loops
- The app provides a highly customized tracking experience that feels tailored for individual bariatric patient needs
- The food database lacks sufficient variety and common items, forcing users to manually input many entries
Analysis in progress
Analysis in progress
Single-market publisher, every app ships only to United States.
Based on 8 of 23 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States8 / 8
Core markets (8/8 apps)
User Sentiment
How do users feel about their apps?
1
Positive apps
1
Neutral / mixed
0
Negative apps
68/100
Avg sentiment score
Unlock the app dragging this portfolio down.
Access the full report for freeRivals
Who does Hussain Mustafa compete with?
The rivals identified
Nemeses(3)
Both apps target chronic condition management through health metric logging, creating direct competition for users seeking a centralized utility to track medication and physiological trends.
Both apps target the weight loss market, but Bariatric Food Tracker focuses on post-surgical nutrition habits while Shotlee targets the growing GLP-1 medication user base.
Both applications target the same niche of GLP-1 medication users by providing specialized tracking for injection schedules and health metrics. They compete directly for users seeking to manage medication cycles and side effects without cost.
Contenders(12)
Both applications target the same user base managing GLP-1 medication regimens, offering overlapping functionality for shot logging, side effect monitoring, and weight tracking.
Both applications target the same patient demographic by providing free, specialized tools for tracking GLP-1 medication injection schedules and health metrics.
Both apps target users managing GLP-1 medication regimens, offering overlapping functionality for tracking injection history, weight trends, and side effects.
GLPeak targets the same user base managing GLP-1 medication regimens, directly competing for daily logging habits through overlapping medication and health metric tracking features.
Both applications target patients managing GLP-1 medication regimens, with Bound focusing on manual logging and Blood Levels providing pharmacokinetic modeling for drug concentration.
Jabby competes for the same medication-tracking audience by focusing on injection reminders and weight trends, directly overlapping with the core injection-logging functionality of GLP 1 Tracker.
Both apps target the same user base of GLP-1 medication users by offering medication logging and health metric tracking at no cost.
known for
GLP-1 Tracker & Shot Log: Remi
Both applications target the same user base managing GLP-1 medications like Ozempic and Mounjaro by providing injection logging and weight tracking tools.
Both apps target individuals using GLP-1 medications like Ozempic and Zepbound, providing shared functionality for logging injections and tracking health metrics.
Both applications target individuals managing GLP-1 medication regimens, providing overlapping functionality for injection logging and weight tracking.
Both applications target individuals managing GLP-1 medication regimens, offering overlapping functionality for logging injection sites, dosages, and health metrics.
Both apps target users managing GLP-1 medication regimens, creating direct competition for users seeking adherence and progress tracking tools.
Same space(39)
Targets chronic condition patients requiring clinical-grade reporting for physician consultations.
Users report: Targets cardiovascular tracking through automated data capture.
Provides a similar medical logbook structure for chronic condition management.
Records and monitors vital health readings for personal management.
Provides clinical-grade growth monitoring for specialized health needs.
Mingo focuses on the emotional and habit-forming aspects of the GLP-1 journey, using a personalized journey card to track milestones.
Serves the same chronic condition management audience by providing comprehensive tracking of glucose, medication, and weight.
Employs high-frequency logging to build consistent health routines.
GLPTracker provides a basic, no-frills digital logbook for patients who prefer a straightforward approach to managing their treatment.
Acts as a direct companion for patients on specific GLP-1 medications, providing dosing reminders and logbooks.
DreamMe uses gamification to maintain user engagement, positioning itself as a supportive companion rather than a clinical utility.
Shares the high-frequency logging habit required for post-operative patients.
Functions as a digital health journal for tracking specific symptoms, overlapping with the side-effect documentation needs of GLP-1 patients.
Dr.GLP1 offers a similar feature set but attempts to capture power users through specialized muscle-protection analytics.
Glapp attempts to build a community-driven platform, focusing on peer comparisons and clinical trial data to validate user progress.
Uses data-driven insights to monitor developmental milestones.
Focuses on high-intent, time-sensitive tracking during medical events.
Facilitates patient-provider connectivity through clinical data sharing.
Targets the same patient demographic managing cardiovascular risks by providing automated hardware synchronization for vital signs.
Coordinates diabetes management through real-time hardware data integration.
MeAgain provides a similar centralized tracking environment, though it focuses on a mascot-based engagement hook to differentiate its daily logging experience.
Uses clinical-grade growth charts to drive long-term retention.
Acts as a clinical source of truth for dietary management of chronic conditions.
PenPal focuses on the physiological needs of the therapy, specifically prioritizing half-life visualization for users on complex protocols.
Manages blood glucose and diet tracking for chronic condition support.
Offers a similar daily habit-logging utility for health metrics.
Noom targets the same weight-loss audience but shifts the focus from simple medication logging to behavioral psychology and clinical coaching.
Shot Pal provides a standard utility set for GLP-1 users, focusing on the core requirement of medication and weight tracking.
Provides a digital interface for tracking fever trends, assisting users in maintaining health records similar to GLP-1 injection logs.
Provides a centralized platform for logging daily activities and health history.
Shotsy competes directly by offering advanced clinical-grade visualization of medication levels, appealing to users who need more than basic injection logs.
Competes for the same weight-loss patient audience by centralizing medication adherence and nutrition tracking.
Offers structured support and dietary guidance for managing hormonal health.
Stackr targets the advanced peptide and GLP-1 user who needs to manage supply inventory alongside dosing schedules.
Assists users in maintaining consistency through session logging and trends.
GLP-1 Tracker offers a privacy-focused utility, though its lack of recent updates makes it a legacy option compared to more active competitors.
Mounjaro Tracker acts as a direct functional alternative, offering a comprehensive suite that combines medication, nutrition, and progress tracking.
Supports GLP-1 medication journeys by integrating nutrition tracking with symptom monitoring.
Centralizes health metrics and developmental milestones for expectant users.
New entrants(1)
Revio provides a high-utility, free-to-use logging interface that leverages wearable integration to keep users engaged.
